| Primary |
| Schizophrenia |
49.1% |
| Bipolar Disorder |
6.4% |
| Psychotic Disorder |
6.2% |
| Insomnia |
5.1% |
| Depression |
4.8% |
| Schizophrenia, Paranoid Type |
4.0% |
| Anxiety |
3.2% |
| Schizoaffective Disorder |
3.1% |
| Constipation |
2.2% |
| Major Depression |
2.1% |
| Diabetes Mellitus |
1.7% |
| Extrapyramidal Disorder |
1.6% |
| Prophylaxis |
1.6% |
| Product Used For Unknown Indication |
1.4% |
| Agitation |
1.4% |
| Bipolar I Disorder |
1.4% |
| Hypertension |
1.3% |
| Obsessive-compulsive Disorder |
1.3% |
| Asperger's Disorder |
1.2% |
| Affective Disorder |
1.1% |
|
| Psychotic Disorder |
24.9% |
| Schizophrenia |
22.9% |
| Sudden Death |
5.7% |
| Completed Suicide |
3.9% |
| Psychiatric Symptom |
3.4% |
| Schizophrenia, Paranoid Type |
3.4% |
| Suicide Attempt |
3.4% |
| Tremor |
3.4% |
| Neuroleptic Malignant Syndrome |
3.0% |
| Tardive Dyskinesia |
3.0% |
| Pulmonary Embolism |
2.7% |
| Inappropriate Antidiuretic Hormone Secretion |
2.5% |
| Mania |
2.5% |
| Suicidal Ideation |
2.5% |
| Death |
2.2% |
| Hypertensive Crisis |
2.2% |
| Rhabdomyolysis |
2.2% |
| Weight Increased |
2.2% |
| Vomiting |
2.0% |
| Weight Decreased |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.0% |
| Schizophrenia |
15.9% |
| Drug Use For Unknown Indication |
10.4% |
| Psychotic Disorder |
6.3% |
| Depression |
6.2% |
| Bipolar Disorder |
6.0% |
| Obsessive-compulsive Disorder |
3.8% |
| Schizoaffective Disorder |
3.2% |
| Schizophrenia, Paranoid Type |
2.2% |
| Bipolar I Disorder |
2.0% |
| Anxiety |
1.8% |
| Abnormal Behaviour |
1.7% |
| Epilepsy |
1.6% |
| Dementia |
1.5% |
| Completed Suicide |
1.4% |
| Depressed Mood |
1.4% |
| Asperger's Disorder |
1.3% |
| Foetal Exposure During Pregnancy |
1.2% |
| Ill-defined Disorder |
1.1% |
| Prophylaxis |
1.1% |
|
| Completed Suicide |
12.8% |
| Weight Increased |
11.9% |
| Death |
8.3% |
| Premature Labour |
6.5% |
| Psychotic Disorder |
5.9% |
| Ventricular Septal Defect |
5.9% |
| Tremor |
5.4% |
| Drug Interaction |
5.0% |
| Neuroleptic Malignant Syndrome |
4.1% |
| Suicide Attempt |
3.7% |
| Toxicity To Various Agents |
3.7% |
| Pulmonary Embolism |
3.5% |
| Weight Decreased |
3.5% |
| Cardio-respiratory Arrest |
3.3% |
| Respiratory Arrest |
3.2% |
| Suicidal Ideation |
3.0% |
| Treatment Noncompliance |
3.0% |
| Blood Creatine Phosphokinase Increased |
2.6% |
| Schizophrenia |
2.4% |
| Rhabdomyolysis |
2.2% |
|
| Concomitant |
| Schizophrenia |
25.0% |
| Product Used For Unknown Indication |
17.7% |
| Depression |
9.3% |
| Drug Use For Unknown Indication |
7.8% |
| Psychotic Disorder |
6.0% |
| Bipolar Disorder |
5.5% |
| Hypertension |
4.5% |
| Schizophrenia, Paranoid Type |
4.0% |
| Schizoaffective Disorder |
2.8% |
| Affective Disorder |
2.3% |
| Rheumatoid Arthritis |
2.3% |
| Anxiety |
2.2% |
| Insomnia |
1.7% |
| Diabetes Mellitus |
1.4% |
| Epilepsy |
1.3% |
| Pain |
1.3% |
| Agitation |
1.2% |
| Bipolar I Disorder |
1.2% |
| Constipation |
1.1% |
| Obsessive-compulsive Disorder |
1.1% |
|
| Weight Increased |
17.9% |
| White Blood Cell Count Decreased |
10.3% |
| White Blood Cell Count Increased |
9.5% |
| Psychotic Disorder |
6.2% |
| Urinary Tract Infection |
5.0% |
| Weight Decreased |
4.6% |
| Granulocytopenia |
4.4% |
| Pancreatitis |
4.2% |
| Vomiting |
4.2% |
| Type 2 Diabetes Mellitus |
3.8% |
| Tachycardia |
3.4% |
| Tremor |
3.4% |
| Hypertension |
3.2% |
| Renal Failure Acute |
3.2% |
| Urinary Incontinence |
3.2% |
| Leukopenia |
3.0% |
| Treatment Noncompliance |
3.0% |
| Neutrophil Count Decreased |
2.8% |
| Drug Interaction |
2.6% |
| Electrocardiogram Qt Prolonged |
2.6% |
|
| Interacting |
| Depression |
17.9% |
| Bipolar Disorder |
9.7% |
| Psychotic Disorder |
9.3% |
| Anxiety |
7.2% |
| Hiv Infection |
7.2% |
| Schizophrenia |
7.2% |
| Schizoaffective Disorder |
6.6% |
| Insomnia |
6.1% |
| Parkinsonism |
3.6% |
| Schizophrenia, Paranoid Type |
3.6% |
| Bronchitis |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Upper Respiratory Tract Inflammation |
2.7% |
| Major Depression |
2.5% |
| Affective Disorder |
2.0% |
| Acquired Immunodeficiency Syndrome |
1.8% |
| Attention Deficit/hyperactivity Disorder |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
| Tourette's Disorder |
1.8% |
| Hypertension |
1.6% |
|
| Psychotic Disorder |
17.5% |
| Drug Interaction |
9.3% |
| Wheezing |
9.3% |
| Parkinsonism |
8.2% |
| Vision Blurred |
8.2% |
| Asthenia |
6.2% |
| Hallucination |
4.1% |
| Neuroleptic Malignant Syndrome |
4.1% |
| Neutropenia |
4.1% |
| Altered State Of Consciousness |
3.1% |
| Delusion |
3.1% |
| Drug Level Increased |
3.1% |
| Oculogyric Crisis |
3.1% |
| Schizophrenia |
3.1% |
| Tardive Dyskinesia |
3.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.1% |
| Dystonia |
2.1% |
| Headache |
2.1% |
| Hypomania |
2.1% |
| Intention Tremor |
2.1% |
|
